Filing Details
- Accession Number:
- 0001209191-13-044777
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-18 18:37:15
- Reporting Period:
- 2013-09-16
- Filing Date:
- 2013-09-18
- Accepted Time:
- 2013-09-18 18:37:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198330 | P Guy Nohra | One Embarcadero Center 37Th Floor San Francisco CA 94111 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-09-16 | 16,398 | $10.75 | 2,778,509 | No | 4 | S | Indirect | ACP IV, L.P. |
Common Stock | Disposition | 2013-09-17 | 49,921 | $10.48 | 2,728,588 | No | 4 | S | Indirect | ACP IV, L.P. |
Common Stock | Disposition | 2013-09-18 | 62,461 | $10.29 | 2,666,127 | No | 4 | S | Indirect | ACP IV, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | ACP IV, L.P. |
No | 4 | S | Indirect | ACP IV, L.P. |
No | 4 | S | Indirect | ACP IV, L.P. |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2013.
- The price reported in Column 4 is a weighted average price. The range of sale prices for the transactions reported was $10.56 to $10.87 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The shares are owned by ACP IV, L.P. ("ACPIV"). ACMP IV, LLC (the "General Partner") serves as the general partner of ACPIV, L.P. and possesses power to direct the voting and disposition of the shares owned by ACPIV and may be deemed to have indirect beneficial ownership of the shares held by ACPIV. The General Partner owns no securities of the Issuer directly. The Reporting Person is a member of the General Partner. As such, the Reporting Person shares voting and investment power over the shares held by ACPIV. The Reporting Person disclaims beneficial ownership of the shares held by ACP IV except to the extent of his proportionate pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. The range of sale prices for the transactions reported was $10.41 to $10.70 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. The range of sale prices for the transactions reported was $10.24 to $10.44 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.